Skip to main content

11-09-2017 | Dabrafenib | Article

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

Planchard D et al. Lancet Oncol 2017; 18(10):1307-1316. doi:10.1016/S1470-2045(17)30679-4

Please log in to get access to this content

Related topics

Thoracic cancers in the 2020 ASCO Virtual Scientific Program

All the news and expert video interviews from the virtual meeting

Image Credits